Format
Sort by
Items per page

Send to

Choose Destination

Links from Books

Items: 1 to 20 of 21

1.
2.

Using positron emission tomography to facilitate CNS drug development.

Lee CM, Farde L.

Trends Pharmacol Sci. 2006 Jun;27(6):310-6. Epub 2006 May 6. Review.

PMID:
16678917
3.

Sequence variation in the human dopamine transporter gene in children with attention deficit hyperactivity disorder.

Mazei-Robison MS, Couch RS, Shelton RC, Stein MA, Blakely RD.

Neuropharmacology. 2005 Nov;49(6):724-36. Epub 2005 Sep 19.

PMID:
16171832
4.
5.

Molecular pathways of neurodegeneration in Parkinson's disease.

Dawson TM, Dawson VL.

Science. 2003 Oct 31;302(5646):819-22. Review.

PMID:
14593166
6.

Plasma membrane monoamine transporters: structure, regulation and function.

Torres GE, Gainetdinov RR, Caron MG.

Nat Rev Neurosci. 2003 Jan;4(1):13-25. Review. No abstract available.

PMID:
12511858
7.
8.

Positron emission tomography: imaging and quantification of neurotransporter availability.

Laruelle M, Slifstein M, Huang Y.

Methods. 2002 Jul;27(3):287-99. Review.

PMID:
12183117
9.

Measurement of dopamine transporter occupancy for multiple injections of cocaine using a single injection of [F-18]FECNT.

Votaw JR, Howell LL, Martarello L, Hoffman JM, Kilts CD, Lindsey KP, Goodman MM.

Synapse. 2002 Jun 15;44(4):203-10.

PMID:
11984856
10.
11.

An admonition when measuring the lipophilicity of radiotracers using counting techniques.

Wilson AA, Jin L, Garcia A, DaSilva JN, Houle S.

Appl Radiat Isot. 2001 Feb;54(2):203-8.

PMID:
11200881
12.

Immunocytochemical localization of the dopamine transporter in human brain.

Ciliax BJ, Drash GW, Staley JK, Haber S, Mobley CJ, Miller GW, Mufson EJ, Mash DC, Levey AI.

J Comp Neurol. 1999 Jun 21;409(1):38-56.

PMID:
10363710
13.

Neurotransmitter receptor and transporter binding profile of antidepressants and their metabolites.

Owens MJ, Morgan WN, Plott SJ, Nemeroff CB.

J Pharmacol Exp Ther. 1997 Dec;283(3):1305-22.

14.

The dopamine transporter is localized to dendritic and axonal plasma membranes of nigrostriatal dopaminergic neurons.

Nirenberg MJ, Vaughan RA, Uhl GR, Kuhar MJ, Pickel VM.

J Neurosci. 1996 Jan 15;16(2):436-47.

15.

Relationship between lipophilicity and brain extraction of C-11-labeled radiopharmaceuticals.

Dishino DD, Welch MJ, Kilbourn MR, Raichle ME.

J Nucl Med. 1983 Nov;24(11):1030-8.

16.

Cocaine receptors on dopamine transporters are related to self-administration of cocaine.

Ritz MC, Lamb RJ, Goldberg SR, Kuhar MJ.

Science. 1987 Sep 4;237(4819):1219-23.

PMID:
2820058
17.

Cocaine receptors: in vivo labeling with 3H-(-)cocaine, 3H-WIN 35,065-2, and 3H-WIN 35,428.

Scheffel U, Boja JW, Kuhar MJ.

Synapse. 1989;4(4):390-2. No abstract available.

PMID:
2603151
18.

The dopamine transporter is absent in parkinsonian putamen and reduced in the caudate nucleus.

Niznik HB, Fogel EF, Fassos FF, Seeman P.

J Neurochem. 1991 Jan;56(1):192-8.

PMID:
1987318
19.

Abnormal dopamine uptake sites in postmortem striatum from patients with Tourette's syndrome.

Singer HS, Hahn IH, Moran TH.

Ann Neurol. 1991 Oct;30(4):558-62.

PMID:
1838678

Supplemental Content

Support Center